Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mirikizumab by Eli Lilly and Co for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Mirikizumab is under clinical development by Eli Lilly and Co and currently in Pre-Registration for Crohn's Disease (Regional Enteritis). According...
Data Insights
Mirikizumab by Eli Lilly and Co for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Mirikizumab is under clinical development by Eli Lilly and Co and currently in Pre-Registration for Crohn's Disease (Regional Enteritis). According...